Back
Reshape Lifesciences Stock Price Chart
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
14
RSLS
Reshape Lifesciences
Last Price:
$0.31
Seasonality Move:
-21.04%
7 Day Trial
ALL ACCESS PASS
$
7
Market's down 10% YTD Buffet's Berkshire up 13%
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RSLS is experiencing selling pressure, which indicates risk of future bearish movement.
Reshape Lifesciences Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.4 | Sell |
| 20-day SMA: | 0.5 | Sell |
| 50-day SMA: | 1.01 | Sell |
| 200-day SMA: | 5.64 | Sell |
| 8-day EMA: | 0.4 | Sell |
| 20-day EMA: | 0.53 | Sell |
| 50-day EMA: | 1.25 | Sell |
| 200-day EMA: | 13.48 | Sell |
Reshape Lifesciences Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.2 | Sell |
| Relative Strength Index (14 RSI): | 40.14 | Sell |
| Chaikin Money Flow: | -3252358 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.28 - 0.78) | Sell |
| Bollinger Bands (100): | (0.89 - 4.81) | Sell |
Reshape Lifesciences Technical Analysis
| Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Reshape Lifesciences Stock
Is Reshape Lifesciences Stock a Buy?
-
Reshape Lifesciences share price is 0.31 while RSLS 8-day simple moving average is 0.40, which is a Sell signal.
-
The stock price of RSLS is 0.31 while Reshape Lifesciences 20-day SMA is 0.50, which makes it a Sell.
-
Reshape Lifesciences 50-day simple moving average is 1.01 while RSLS share price is 0.31, making it a Sell technically.
-
RSLS stock price is 0.31 and Reshape Lifesciences 200-day simple moving average is 5.64, creating a Sell signal.
RSLS Technical Analysis vs Fundamental Analysis
Sell
14
Reshape Lifesciences (RSLS)
is a Sell
Is Reshape Lifesciences a Buy or a Sell?
-
Reshape Lifesciences stock is rated a SellThe current Reshape Lifesciences [RSLS] share price is $0.31. The Score for RSLS is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
Reshape Lifesciences Stock Info
Market Cap:
3.5M
Price in USD:
0.31
Share Volume:
4.5M
Reshape Lifesciences 52-Week Range
52-Week High:
29.00
52-Week Low:
0.30
Sell
14
Reshape Lifesciences (RSLS)
is a Sell
Reshape Lifesciences Share Price Forecast
-
What is the Reshape Lifesciences stock price today?The Reshape Lifesciences stock price is 0.31 USD today.
-
Will RSLS stock go up or go down?Reshape Lifesciences> share price is forecast to RISE/FALL based on technical indicators
-
Is Reshape Lifesciences overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Reshape Lifesciences is overvalued.
Is Reshape Lifesciences Stock a Buy?
-
Reshape Lifesciences share price is 0.31 while RSLS 8-day exponential moving average is 0.40, which is a Sell signal.
-
The stock price of RSLS is 0.31 while Reshape Lifesciences 20-day EMA is 0.53, which makes it a Sell.
-
Reshape Lifesciences 50-day exponential moving average is 1.25 while RSLS share price is 0.31, making it a Sell technically.
-
RSLS stock price is 0.31 and Reshape Lifesciences 200-day simple moving average is 13.48, creating a Sell signal.
Fundamental Analysis of Reshape Lifesciences
Is Reshape Lifesciences a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Reshape Lifesciences
Should I short Reshape Lifesciences stock?
-
RSLS Moving Average Covergence Divergence (MACD) indicator is -0.2, suggesting Reshape Lifesciences is a Sell
-
Reshape Lifesciences Relative Strength Index (RSI) is 40.14, which suggest Reshape Lifesciences is oversold
-
The Bollinger Bands (25) for Reshape Lifesciences is (0.28 - 0.78), which suggest Reshape Lifesciences is a Sell
-
The Bollinger Bands (100) for Reshape Lifesciences is (0.89 - 4.81), which suggest Reshape Lifesciences is a Sell
* Reshape Lifesciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.